NCT06242795View on ClinicalTrials.gov

Hypertonic Saline in NCFB

PHASE4RecruitingINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

October 23, 2024

Primary Completion Date

June 30, 2026

Study Completion Date

June 30, 2026

Conditions
BronchiectasisNon-cystic Fibrosis Bronchiectasis
Interventions
DRUG

7% Hypertonic Saline via nebulization

Twice a day treatment with nebulized 7% HS for 2 weeks as part of airway clearance

Trial Locations (1)

27514

RECRUITING

University of North Carolina at Chapel Hill, Chapel Hill

All Listed Sponsors
collaborator

Cystic Fibrosis Foundation

OTHER

lead

University of North Carolina, Chapel Hill

OTHER

NCT06242795 - Hypertonic Saline in NCFB | Biotech Hunter | Biotech Hunter